Kutteh William H, Hinote Candace D
Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA; Fertility Associates of Memphis, PLLC, 80 Humphreys Center, Suite 307, Memphis, TN 38120, USA.
MidSouth OB GYN, 6215 Humphreys Boulevard, Suite 100, Memphis, TN 38120, USA.
Obstet Gynecol Clin North Am. 2014 Mar;41(1):113-32. doi: 10.1016/j.ogc.2013.10.004.
Antiphospholipid antibodies (aPLs) are acquired antibodies directed against negatively charged phospholipids. Obstetric antiphospholipid antibody syndrome (APS) is diagnosed in the presence of certain clinical features in conjunction with positive laboratory findings. Obstetric APS is one of the most commonly identified causes of recurrent pregnancy loss. Thus, obstetric APS is distinguished from APS in other organ systems where the most common manifestation is thrombosis. Several pathophysiologic mechanisms of action of aPLs have been described. This article discusses the diagnostic and obstetric challenges of obstetric APS, proposed pathophysiologic mechanisms of APS during pregnancy, and the management of women during and after pregnancy.
抗磷脂抗体(aPLs)是针对带负电荷磷脂的获得性抗体。产科抗磷脂抗体综合征(APS)是在存在某些临床特征并伴有实验室检查结果阳性的情况下做出诊断的。产科APS是复发性流产最常见的确定病因之一。因此,产科APS与其他器官系统的APS不同,后者最常见的表现是血栓形成。已经描述了aPLs的几种病理生理作用机制。本文讨论了产科APS的诊断和产科挑战、妊娠期APS可能的病理生理机制以及妊娠期及产后女性的管理。